Royalty Pharma plc (RPRX)

Royalty Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,088	929.03	477.01	1,711	1,541	1,009
Short-Term Investments	12.1	58.2	18.3	25.72	647.87	1,053
Cash & Short-Term Investments	1,100	987.23	495.31	1,736	2,189	2,062
Cash Growth	26.13%	99.31%	-71.48%	-20.67%	6.16%	505.29%
Accounts Receivable	740.34	810.73	760.84	727.92	682.66	626.36
Receivables	740.34	810.73	760.84	727.92	682.66	626.36
Other Current Assets	3.08	4.19	18.04	90.52	6.63	8.6
Total Current Assets	1,843	1,802	1,274	2,555	2,878	2,697
Long-Term Investments	696.29	1,260	1,012	735.82	909.59	916.64
Other Intangible Assets	5.32	5.32	1.78	14.5	5.67	28.67
Long-Term Accounts Receivable	15,032	15,127	14,089	13,493	13,718	12,368
Other Long-Term Assets	31.38	28.21	4.74	15.13	4.14	10
Total Assets	17,608	18,223	16,382	16,813	17,516	16,020
Accounts Payable	37.63	13.37	15.17	7.91	5.62	10.78
Accrued Expenses	19.22	98.06	51.68	54.16	57.7	60.75
Current Portion of Long-Term Debt	998.61	997.77	-	997.51	-	-
Other Current Liabilities	127.4	144.41	94.53	107.2	107.93	236.37
Total Current Liabilities	1,183	1,254	161.38	1,167	171.25	307.89
Long-Term Debt	6,619	6,615	6,135	6,119	7,096	5,817
Other Long-Term Liabilities	17.9	12.08	0.9	2.5	-	-
Total Liabilities	7,820	7,880	6,298	7,288	7,267	6,124
Common Stock	0.11	0.11	0.11	0.11	0.11	0.1
Additional Paid-In Capital	4,211	4,103	4,011	3,666	3,508	2,866
Retained Earnings	2,481	2,846	2,518	1,965	2,255	1,921
Treasury Stock	-2.65	-2.66	-2.63	-2.81	-2.72	-2.32
Comprehensive Income & Other	-	-	-	-	16.49	34.4
Total Common Equity	6,689	6,947	6,526	5,628	5,777	4,819
Minority Interest	3,100	3,396	3,558	3,897	4,472	5,077
Shareholders' Equity	9,789	10,342	10,084	9,525	10,249	9,896
Total Liabilities & Equity	17,608	18,223	16,382	16,813	17,516	16,020
Total Debt	7,617	7,612	6,135	7,116	7,096	5,817
Net Cash (Debt)	-6,518	-6,625	-5,640	-5,380	-4,907	-3,755
Net Cash Per Share	-11.06	-11.15	-9.35	-12.28	-11.83	-10.00
Filing Date Shares Outstanding	421.37	433.32	446.69	443.17	432.96	388.13
Total Common Shares Outstanding	425.59	445.99	446.69	443.17	432.96	388.14
Working Capital	660.39	548.52	1,113	1,388	2,707	2,389
Book Value Per Share	15.72	15.58	14.61	12.70	13.34	12.42
Tangible Book Value	6,683	6,941	6,525	5,614	5,771	4,790
Tangible Book Value Per Share	15.70	15.56	14.61	12.67	13.33	12.34

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q